RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Boston, MA · Waltham, MA · +111 more sites
8 recruiting migraine studies with a site in Boston, MA.
Sponsor: Kallyope Inc.
Boston, MA · Waltham, MA · +111 more sites
Sponsor: Pfizer
Boston, MA · Waltham, MA · +167 more sites
Sponsor: Kallyope Inc.
Boston, MA · Waltham, MA · +111 more sites
Sponsor: Brigham and Women's Hospital
Boston, MA
Sponsor: Brigham and Women's Hospital
Boston, MA
Sponsor: Beth Israel Deaconess Medical Center
Boston, MA
Sponsor: Brigham and Women's Hospital
Boston, MA
Sponsor: Brigham and Women's Hospital
Boston, MA · Chestnut Hill, MA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.